tiprankstipranks
Trending News
More News >
Elekta AB (DE:EJX)
MUNICH:EJX

Elekta AB (EJX) Price & Analysis

Compare
1 Followers

EJX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.02%<0.01%99.97%
Insiders
0.02%
Mutual Funds
<0.01% Other Institutional Investors
99.97% Public Companies and
Individual Investors

EJX FAQ

What was Elekta AB’s price range in the past 12 months?
Elekta AB lowest stock price was €4.28 and its highest was €6.15 in the past 12 months.
    What is Elekta AB’s market cap?
    Elekta AB’s market cap is $1.68B.
      When is Elekta AB’s upcoming earnings report date?
      Elekta AB’s upcoming earnings report date is Aug 28, 2025 which is in 61 days.
        How were Elekta AB’s earnings last quarter?
        Elekta AB released its earnings results on May 28, 2025. The company reported -€0.086 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.086.
          Is Elekta AB overvalued?
          According to Wall Street analysts Elekta AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Elekta AB pay dividends?
            Elekta AB pays a Semiannually dividend of €0.104 which represents an annual dividend yield of 0.41%. See more information on Elekta AB dividends here
              What is Elekta AB’s EPS estimate?
              Elekta AB’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Elekta AB have?
              Elekta AB has 368,588,000 shares outstanding.
                What happened to Elekta AB’s price movement after its last earnings report?
                Elekta AB reported an EPS of -€0.086 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Elekta AB?
                  Currently, no hedge funds are holding shares in DE:EJX

                  Elekta AB Stock Smart Score

                  2
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -15.50%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  2.15%
                  Trailing 12-Months
                  Asset Growth
                  1.78%
                  Trailing 12-Months

                  Company Description

                  Elekta AB

                  Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

                  EJX Company Deck

                  EJX Earnings Call

                  Q4 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Neutral
                  The earnings call presented a mix of strong performance in Europe and solid financial metrics against challenges in the U.S. market, noncash impairments, and slight declines in certain regions like China. Overall, the company demonstrated resilience and positioned for future growth but faced significant hurdles that balanced the positive aspects.Read More>
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Haemonetics
                  Merit Medical Systems
                  QuidelOrtho
                  Staar Surgical
                  NovoCure
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis